(RTTNews) - Abbott (ABT) Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, ...

Abbott Laboratories, a firm that ranks #3 on The Top 100 Medical Device Companies List, might have been late to the pulsed-field ablation party, but don’t count it out. New data presented from the ...

The highly competitive pulsed field ablation (PFA) market is welcoming a new entrant after Abbott secured CE marking for its Volt system to treat patients with atrial fibrillation (AFib). Abbott had ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

Abbott Laboratories snagged a CE mark for its Volt pulsed field ablation catheter for atrial fibrillation several months earlier than the mid-year approval expected. The Abbott Park, Ill.-based ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an approval in Europe for its Volt system. Boston Scientific, Medtronic and ...

Add Yahoo as a preferred source to see more of our stories on Google. Abbott's Volt pulsed field ablation catheter. Abbott said Monday that it has received Food and Drug Administration approval for ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its Volt PFA System to treat atrial fibrillation. The highly anticipated ...

Two years after the U.S. FDA approved the first pulsed field ablation system, Abbott Laboratories finally got the regulatory nod for its Volt PFA system. Abbott follows Medtronic plc, Boston ...

Abbott Laboratories ABT recently received FDA approval for its Volt PFA System to treat patients battling atrial fibrillation (AFib). The company is expected to begin commercial PFA cases in the ...